Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2021 Sep 1;41(9):e64-e65.
doi: 10.1097/IAE.0000000000003211.

Correspondence

Affiliations
Comment

Correspondence

Alankrita Muralidhar et al. Retina. .
No abstract available

PubMed Disclaimer

Comment in

  • Reply.
    Ozsaygili C, Duru N. Ozsaygili C, et al. Retina. 2021 Sep 1;41(9):e65-e66. doi: 10.1097/IAE.0000000000003212. Retina. 2021. PMID: 34001819 No abstract available.

Comment on

References

    1. Ozsaygili C, Duru N. Comparison of intravitreal dexamethasone implant and aflibercept in patients with treatment-naive diabetic macular edema with serous retinal detachment. Retina 2020;40:1044–1052.
    1. Bakbak B, Ozturk BT, Gonul S, Gedik S. The effect of intravitreal bevacizumab and ranibizumab on macular edema of the contralateral eye: a comparative study of two anti-VEGFs. Oman J Ophthalmol 2016 ;9:44–48.
    1. Avery RL, Castellarin AA, Steinle NC, et al. Systemic pharmacokinetics following intravitreal injections of ranibizumab, bevacizumab or aflibercept in patients with neovascular AMD. Br J Ophthalmol 2014 ;98:1636–1641.
    1. Choi M, Jee D, Kwon J. Characteristics of diabetic macular edema patients refractory to anti-VEGF treatments and a dexamethasone implant. PLoS One 2019;14:e0222364.
    1. Callanan DG, Gupta S, Boyer DS, et al. Dexamethasone intra-vitreal implant in combination with laser photocoagulation for the treatment of diffuse diabetic macular edema. Ophthalmology 2013;120:1843–1851.

LinkOut - more resources